Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Treatment Approach Name | Lorlatinib |
| Profile Name | EML4 - ALK ALK S1206Y |
| Drug Class | |
| Therapy | Lorlatinib |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (26144315) | PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models. | Full reference... |